Trial Profile
Assessing Virologic Success and Metabolic Changes in Patients Switching From a TDF to TAF Containing Antiretroviral Therapy Regimen
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Sep 2019
Price :
$35
*
At a glance
- Drugs Tenofovir alafenamide (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 20 Sep 2019 Status changed from recruiting to completed.
- 31 Aug 2018 New trial record